Current Report Filing (8-k)
October 27 2014 - 5:22PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 24, 2014
INVENSENSE, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
001-35269 |
|
01-0789977 |
(State or other Jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification Number) |
1745 Technology Drive, San Jose, Suite 200, CA 95110
(Address of Principal Executive Offices)(Zip Code)
Registrants telephone number, including area code: (408) 988-7339
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On October 24, 2014, InvenSense, Inc. (the Company) appointed Emiko Higashi and Amir Faintuch to serve as members of its Board of Directors
(the Board). Ms. Higashi was designated a Class III director and will stand for re-election at the 2017 Annual Meeting of Stockholders. Ms. Higashi was appointed to the Audit Committee effective immediately following the filing
of the Companys Form 10-Q for the second quarter of fiscal year 2015. Eric Stang will resign from the Audit Committee upon Ms. Higashis appointment to the Audit Committee.
Mr. Faintuch was designated a Class II director and will stand for re-election at the 2016 Annual Meeting of Stockholders.
In connection with their appointment, Ms. Higashi and Mr. Faintuch entered in the Companys standard form of indemnification agreement.
In connection with their service as a director, Ms. Higashi and Mr. Faintuch will each receive compensation for their service as a non-employee
director, as described under Item 8.01 of this Current Report on Form 8-K, which is incorporated herein by reference.
Effective October 21, 2014, the Company adopted a new compensation policy for its
non-employee directors. Pursuant to this new policy, non-employee directors are entitled to the compensation set forth below for their service as a member of the Board.
Initial Equity Grants. Each non-employee director who joins the Board receives an option to purchase 60,000 shares of the Companys common stock,
with 1/48th of the shares subject to the option vesting on a monthly basis over four years, subject to the directors continuous service as a member of the Board. The exercise price of these options is the fair market value on the date of
grant. If still vesting, the grant accelerates in full upon a change in control of the Company.
Retainers. Each non-employee director receives
annual cash retainers, payable quarterly in arrears. The unpaid amounts of these retainers are payable in full for the current fiscal year in the event of a change of control of the Company during that fiscal year. The annual retainer for service on
the Board is $25,000, and the annual retainers for service on committees of the Board is as follows:
|
|
|
|
|
|
|
|
|
Audit Committee |
|
Compensation Committee |
|
|
Nominating Committee |
|
Chair: $15,000 Member: $6,500 |
|
|
Chair: $10,000
Member: $5,000 |
|
|
|
Chair: $7,000 Member:
$3,000 |
|
Annual Equity Grants. Commencing January 1, 2015, each non-employee director with twelve or more months of service
on the Board as of January 1st of each year will be awarded restricted stock units equal in value to $200,000. These annual awards will vest in full twelve months after the date of grant, subject to the directors continuous service as a
member of the Board. Any such grant which has commenced vesting will accelerate in full upon a change of control of the Company.
The new annual grants
are phased in over the next year for all directors based on the following categories: (i) new directors, with less than twelve months of continuous service, (ii) directors who received annual grants of options in 2014 under the prior
director compensation plan, and (iii) directors who were entitled to receive annual grants of options in 2014 under the prior director compensation plan, but did not receive such grant prior to the effectiveness of the current plan.
Phase in for New Directors. Commencing on January 1, 2015, each non-employee director with at least one month of service but less than twelve
months of service on the Board as of January 1st will be awarded on such date a restricted stock unit award equal in value to the product of (a) $200,000 multiplied by (b) the quotient of (i) the number of days that the director
has served on the Board as of the grant date divided by (ii) 365.
Phase in for Directors who Received Annual Option Grants in 2014. For non-employee directors who received
an annual grant of options in 2014, the value of the 2015 annual grant for each such director will equal the product of (a) $200,000 multiplied by (b) the quotient of (i) the number of days from the date of grant of the
directors 2014 annual option award through December 31, 2014, divided by (ii) 365.
Phase in for Directors Entitled to Receive
Annual Option Grants in 2014 Under the Prior Plan. Each non-employee director who would have been entitled to a 2014 annual option grant on or after October 21, 2014, under the non-employee director compensation policy in effect
prior to October 21, 2014, will instead be awarded on such date a restricted stock unit award equal in value to the product of (a) $200,000 multiplied by (b) the quotient of (i) the number of days between the date of grant and
December 31, 2014, divided by (ii) 365. This grant will vest in full on December 31, 2014, subject to the non-employee directors continuous service to the Company through that date. If still vesting, the equity grant will
accelerate in full upon a Change in Control.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: October 27, 2014
|
|
|
INVENSENSE, INC. |
|
|
By: |
|
/s/ Adam Tachner |
|
|
Adam Tachner |
|
|
Vice President and General Counsel |
Invensense, Inc. (NYSE:INVN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Invensense, Inc. (NYSE:INVN)
Historical Stock Chart
From Aug 2023 to Aug 2024